Annual Total Liabilities
$69.43 M
-$9.77 M-12.34%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual total liabilities is $69.43 million, with the most recent change of -$9.77 million (-12.34%) on December 31, 2022.
- During the last 3 years, EVLO annual total liabilities has risen by +$38.71 million (+126.00%).
- EVLO annual total liabilities is now -12.34% below its all-time high of $79.20 million, reached on December 31, 2021.
Performance
EVLO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$47.33 M
-$19.61 M-29.29%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly total liabilities is $47.33 million, with the most recent change of -$19.61 million (-29.29%) on September 30, 2023.
- Over the past year, EVLO quarterly total liabilities has dropped by -$29.67 million (-38.53%).
- EVLO quarterly total liabilities is now -43.23% below its all-time high of $83.38 million, reached on September 30, 2021.
Performance
EVLO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EVLO Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.3% | -38.5% |
3 y3 years | +126.0% | -13.0% |
5 y5 years | +368.9% | +90.5% |
EVLO Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -12.3% | at low | -40.2% | at low |
5 y | 5-year | -12.3% | +126.0% | -43.2% | +54.1% |
alltime | all time | -12.3% | +432.3% | -43.2% | +219.6% |
Evelo Biosciences Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $47.33 M(-29.3%) |
Jun 2023 | - | $66.94 M(-3.5%) |
Mar 2023 | - | $69.36 M(-0.1%) |
Dec 2022 | $69.43 M(-12.3%) | $69.43 M(-9.8%) |
Sep 2022 | - | $77.00 M(+1.0%) |
Jun 2022 | - | $76.25 M(+0.8%) |
Mar 2022 | - | $75.63 M(-4.5%) |
Dec 2021 | $79.20 M(+31.7%) | $79.20 M(-5.0%) |
Sep 2021 | - | $83.38 M(+0.5%) |
Jun 2021 | - | $82.97 M(+27.2%) |
Mar 2021 | - | $65.20 M(+8.4%) |
Dec 2020 | $60.15 M | $60.15 M(+10.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $54.41 M(+21.7%) |
Jun 2020 | - | $44.70 M(+2.0%) |
Mar 2020 | - | $43.80 M(+42.6%) |
Dec 2019 | $30.72 M(+34.1%) | $30.72 M(+0.4%) |
Sep 2019 | - | $30.59 M(+17.1%) |
Jun 2019 | - | $26.12 M(+13.3%) |
Mar 2019 | - | $23.05 M(+0.6%) |
Dec 2018 | $22.92 M(+54.8%) | $22.92 M(-7.8%) |
Sep 2018 | - | $24.85 M(+6.9%) |
Jun 2018 | - | $23.24 M(+10.4%) |
Mar 2018 | - | $21.06 M(+42.2%) |
Dec 2017 | $14.81 M(+13.5%) | $14.81 M |
Dec 2016 | $13.04 M | - |
FAQ
- What is Evelo Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Evelo Biosciences?
- What is Evelo Biosciences annual total liabilities year-on-year change?
- What is Evelo Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Evelo Biosciences?
- What is Evelo Biosciences quarterly total liabilities year-on-year change?
What is Evelo Biosciences annual total liabilities?
The current annual total liabilities of EVLO is $69.43 M
What is the all time high annual total liabilities for Evelo Biosciences?
Evelo Biosciences all-time high annual total liabilities is $79.20 M
What is Evelo Biosciences annual total liabilities year-on-year change?
Over the past year, EVLO annual total liabilities has changed by -$9.77 M (-12.34%)
What is Evelo Biosciences quarterly total liabilities?
The current quarterly total liabilities of EVLO is $47.33 M
What is the all time high quarterly total liabilities for Evelo Biosciences?
Evelo Biosciences all-time high quarterly total liabilities is $83.38 M
What is Evelo Biosciences quarterly total liabilities year-on-year change?
Over the past year, EVLO quarterly total liabilities has changed by -$29.67 M (-38.53%)